Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,895 | -6,676 | -4,301 | -14,858 | -11,681 |
| Depreciation Amortization | 3 | 2 | 1 | 3 | 2 |
| Accounts payable and accrued liabilities | -267 | -935 | 373 | -3,634 | -1,806 |
| Other Working Capital | -926 | -1,995 | 996 | -3,694 | -1,269 |
| Other Operating Activity | 326 | 1,019 | -310 | 5,069 | 3,112 |
| Operating Cash Flow | $-10,759 | $-8,585 | $-3,242 | $-17,113 | $-11,642 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -4 | N/A |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-4 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 13,548 | 13,548 | 9,033 | 23,398 | 18,393 |
| Other Financing Activity | 614 | 706 | 795 | -368 | -326 |
| Financing Cash Flow | $14,162 | $14,254 | $9,828 | $23,030 | $18,067 |
| Beginning Cash Position | 6,461 | 6,461 | 6,461 | 549 | 549 |
| End Cash Position | 9,864 | 12,130 | 13,048 | 6,461 | 6,973 |
| Net Cash Flow | $3,403 | $5,669 | $6,586 | $5,913 | $6,424 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,759 | -8,585 | -3,242 | -17,113 | -11,642 |
| Capital Expenditure | N/A | N/A | N/A | -4 | N/A |
| Free Cash Flow | -10,759 | -8,585 | -3,242 | -17,118 | -11,642 |